Form 4 for AKBA Akebia Therapeutics, Inc.
Accepted 2022-03-02 00:00:00 ET · period of report 2022-02-28 · accession 0001562180-22-002164 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-02 | 2022-02-28 | AKBA | Cotreau Violetta | SVP, CAO | A - Grant | $0.00 | +40.8K | 70.0K | +140% | $0 |
| D | 2022-03-02 | 2022-02-28 | AKBA | Cotreau Violetta | SVP, CAO | S - Sale | $2.15 | -3,946 | 29.1K | -12% | -$8,484 |
| D | 2022-03-02 | 2022-02-28 | AKBA | Cotreau Violetta | SVP, CAO | A - Grant | $0.00 | +70.0K | 70.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-28 | A | A | 40,833 | $0.00 | 69,954 | D | — | — | (F2) The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One-third of the restricted stock units will become vested on the first anniversary of the grant date; and the remaining 2/3 of the Shares will vest in substantially equal quarterly installments thereafter, at the beginning of each of the following eight calendar quarters, subject to the reporting person's continued service with the Issuer on each vesting date. |
| 2 | Common | Common Stock | 2022-02-28 | S | D | 3,946 | $2.15 | 29,121 | D | — | — | (F1) This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021. |
| 3 | Derivative | Employee Stock Option (Right to buy) | 2022-02-28 | A | A | 70,000 | $0.00 | 70,000 | D | $2.16 · — to 2032-02-28 | 70,000 Common Stock | (F3) The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date. |